Brainsway (BWAY) EPS (Basic) (2025 - 2026)

Brainsway posted quarterly EPS (Basic) of $5.22 for Q1 2026, down 99.99% year-on-year from $36900.0 in Q1 2025, and down 99.99% on a QoQ basis from $36900.0 in Q1 2025.

Brainsway (BWAY) has 2 years of EPS (Basic) data on file, last reported at $5.22 in Q1 2026.

  • For the quarter ending Q1 2026, EPS (Basic) fell 99.99% year-over-year to $5.22; the trailing twelve-month figure through Mar 2026 stood at $36905.2 (changed 0.01% YoY), and the FY2025 full-year result was $0.2, up 122.22% from the prior year.
  • EPS (Basic) for Q1 2026 stood at $5.22, down from $36900.0 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $36900.0 in Q1 2025 and bottomed at $5.22 in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 0.62
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 1.95
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 0.89
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 0.90
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 0.66
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 0.52
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 0.85
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 2.25
10 Brainsway 6.80 Mn -52.98 Mn 11.68 Mn 5.22

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 5.22
Mar 31, 2025 36,900.00